Jushi Holdings Inc. (JUSHF)
(Delayed Data from OTC)
$0.56 USD
+0.01 (1.82%)
Updated Jul 10, 2024 03:02 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Jushi Holdings Inc. [JUSHF]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: Jushi Holdings Inc.
Industry: Medical - Products
Company: Jushi Holdings Inc.
Industry: Medical - Products
In Line Q423 Results with Opex Cuts Supporting the Bottom Line
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Jushi Holdings Inc.
Industry: Medical - Products
Due to an analyst departure, we are discontinuing coverage.
Provider: VENTUM CAPITAL MARKETS
Analyst: Research Department
Company: Jushi Holdings Inc.
Industry: Medical - Products
Q323 Results Underwhelm, But Model Review Uncovers Outsized Torque to Possible Rescheduling Catalyst.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Jushi Holdings Inc.
Industry: Medical - Products
Weekly ReHash: An Update on Cannabis Capital Raising
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Jushi Holdings Inc.
Industry: Medical - Products
Another Quarter with Sales Below Forecasts But Margins and Profitability Post Large Beats, Opex Cuts Achieved with Focus on Returning to Revenue Growth
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Jushi Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Rescheduling Process Recommendation Expected By Year End
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Jushi Holdings Inc.
Industry: Medical - Products
Mixed Q123 Results a Net Positive as Management Takes Corrective Actions to Improve Cashflow, Liquidity Sufficient for 2023 after $20M Mortgage Financing
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Jushi Holdings Inc.
Industry: Medical - Products
Q422 Showed Steep Step-up in Profitability Though More Required to Hit Breakeven FCF, Additional Capital May be Required Within 3-6 Months
Provider: Echelon Welath Partners
Analyst: SEMPLE A
|